Executive Insider Buying Signals a Bullish Bet on ENGENE THERAPEUTICS Amid Tumour Vaccine Hopes
Insider buying signals confidence in ENGENE’s cancer‑vaccine pipeline—explore why executives are purchasing shares amid a volatile stock.
3 minutes to read